MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Aging"

  • MDS Virtual Congress 2020

    Disease progression characterized by motor performance, dopaminergic neurodegeneration and T cell infiltration in the transgenic hm2-α-SYN-39 mouse model of Parkinson´s disease

    J. Behnke, L. Rauschenberger, S. Knorr, J. Volkmann, C.W Ip (Wuerzburg, Germany)

    Objective: To study disease progression in the transgenic (tg) hm2-α-SYN-39 mouse model of Parkinson´s disease (PD) by assessment of motor performance, dopaminergic neurodegeneration and T…
  • MDS Virtual Congress 2020

    Relationship between tumor and very slow Parkinson`s disease progression

    H. Mori (Kurashiki, Okayama, Japan)

    Objective: We evaluate the Parkinson`s disease patients with very slow progression. One of their clinical features are the medical history of tumor. Background: Some cancer…
  • MDS Virtual Congress 2020

    Age at onset and Parkinson’s disease progression

    G. D'Urso, K. Taylor, T. Kustermann, N. Pavese, G. Pagano (Basel, Switzerland)

    Objective: Explore whether age at onset of Parkinson’s disease influences the rate of early disease progression. Background: In cross-sectional studies, older age at onset has…
  • MDS Virtual Congress 2020

    Effects of a community-based adapted boxing program on physical capacity and quality of life in individuals with Parkinson disease over a 12 month period

    S. Benoit, E. Riesco, A. Tanguay (Sherbrooke, QC, Canada)

    Objective: The main objective was to assess long-term effects of a community-based adapted boxing program on physical capacity and QoL in individuals with mild, or…
  • 2019 International Congress

    In vivo and In vitro study of 17β estradiol against amyloid beta neurotoxicity in synaptosomes of aging female rats : A therapeutic potential drug for Alzheimer’s disease

    P. Kumar, N. Baquer (New Delhi, India)

    Objective: The aim of the present study was to determine the effects of neuropeptide, neurokinin B (NKB) and amyloid beta fragment Aβ (25-35) on 17β…
  • 2019 International Congress

    Pupillary response to light and tasks in early and late onset essential tremor patients

    J. Becktepe, F. Gövert, L. Kasiske, M. Yalaz, K. Witt, G. Deuschl (Kiel, Germany)

    Objective: Testing the hypothesis that late onset essential tremor (LOET) patients show age-typical differences of the pupillary responses when compared with early onset ET (EOET)…
  • 2019 International Congress

    SNP assessment and gene expression analysis of alpha-synuclein (SNCA), LRRK2 gene and parkin (PRKN) gene in chewing tobacco exposures and find out the risk of Parkinson’s disease

    R. Ramachandran, E. E, V. Uthayakumar (Erode, India)

    Objective: We aimed to find out the molecular assessment of the risk of Parkinson’s disease (PD) in tobacco exposure through the SNP and gene expression…
  • 2019 International Congress

    Mindfulness Training to Reduce Anxiety in Parkinson’s Disease: A Cautionary Tale about Wearable Technology

    D. Mohanty, A. Lingaiah, J. Doak, A. Jacob, R. Castellanos, V. Holiday, A. Espay, K. Lafaver (Louisville, KY, USA)

    Objective: This study aimed to determine the feasibility of using a non-pharmacologic intervention (mindfulness training; MT) administered with a wearable tracker to alleviate anxiety through…
  • 2019 International Congress

    The longevity gene Klotho and its CSF protein profiles as modifier for Parkinson´s disease in a longitudinal study

    M. Zimmermann, S. Lerche, C. Schulte, I. Wurster, G. Machetanz, C. Deuschle, A. Hauser, T. Gasser, D. Berg, E. Schleicher, W. Maetzler, K. Brockmann (Tuebingen, Germany)

    Objective: Our objective was to evaluate phenotype modifying effects of variants in longevity genes in PD. Background: Parkinson´s disease (PD) has a large phenotypic variability,…
  • 2019 International Congress

    Higher probability of prodromal Parkinson’s disease is related to lower performance in all cognitive domains

    A. Bougea, M. Maraki, M. Yannakoulia, M. Stamelou, G. Xiromerisiou, M. Kosmidis, E. Dardiotis, G. Hadjigeorgiou, P. Sakka, C. Anastasiou, L. Stefanis, N. Scarmeas (Athens, Greece)

    Objective: to assess prodromal Parkinson disease (PD) probability and relate it to detailed cognitive performance in a community cohort. Background: There is a limited information…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 26
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley